[Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in gastric cancer patients]. 1988

Y Tabuchi, and H Deguchi, and Y Saitoh
Kobe University School of Allied Medical Science, Japan.

Correlation between CEA and CA19-9 levels of peripheral and draining venous blood, and 11 histopathologic and 2 immunohistochemical variables, was examined in 53 gastric cancer patients. CEA levels of draining blood were significantly higher than those of peripheral blood in 48 patients with CEA producing cancer. CA19-9 levels of draining blood were not different from those of peripheral blood in 33 patients with CA19-9 producing cancer. Elevation of CEA levels in the blood was most highly correlated with venous invasion, though the levels in draining blood were related to other 10 variables except tumor location and CEA distributed patterns of cancer lesions. These 10 variables relating to CEA elevation were highly associated with venous invasion. However, tumor location and CEA distributed patterns were not associated with venous invasion. While, elevation of CA19-9 levels in the blood was most highly correlated with lymphatic invasion and node metastasis, though the levels were related to the almost same variables which were highly associated with lymphatic invasion and node metastasis as CEA elevation-relating variables. These results suggest that CEA may be hematogenously drained by the portal system via the draining vein from the CEA producing cancer cells in the invasive veins, and that CA19-9 may be drained by the thoracic duct of lymphatic system.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens

Related Publications

Y Tabuchi, and H Deguchi, and Y Saitoh
March 1996, Minerva chirurgica,
Y Tabuchi, and H Deguchi, and Y Saitoh
January 1990, Journal of gastroenterology and hepatology,
Y Tabuchi, and H Deguchi, and Y Saitoh
February 1988, Gan no rinsho. Japan journal of cancer clinics,
Y Tabuchi, and H Deguchi, and Y Saitoh
January 2024, Clinica chimica acta; international journal of clinical chemistry,
Y Tabuchi, and H Deguchi, and Y Saitoh
October 2021, Surgery today,
Y Tabuchi, and H Deguchi, and Y Saitoh
January 1996, The American journal of gastroenterology,
Y Tabuchi, and H Deguchi, and Y Saitoh
November 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association,
Y Tabuchi, and H Deguchi, and Y Saitoh
December 2000, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,
Y Tabuchi, and H Deguchi, and Y Saitoh
March 2016, Molecular and clinical oncology,
Copied contents to your clipboard!